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AbstrACt
Introduction The gut microbiota plays a main role in 
the maintenance of host’s health. Exposure to different 
conditions in early life contributes to distinct ‘pioneer’ 
bacterial communities in the intestine, which shape 
the newborn infant development. Newborn infants 
with congenital malformations of the gastrointestinal 
tract (CMGIT), necrotising enterocolitis (NEC) and 
spontaneous intestinal perforation (SIP) commonly require 
abdominal surgery and enterostomy. The knowledge 
about the colonisation of these newborns’ intestine by 
microorganisms is scarce. This protocol is designed 
to explore the microbial colonisation over time of the 
proximal intestinal remnant in newborn infants who 
underwent surgery for CMGIT, NEC or SIP and require 
enterostomy.
Methods and analysis The literature about microbiota 
colonisation in newborn infants with enterostomy was 
reviewed and an observational, longitudinal, prospective 
study was designed. The infants will be recruited at 
the Neonatal Intensive Care Unit of the Hospital Dona 
Estefânia, Centro Hospitalar Universitário de Lisboa 
Central. Samples of the enterostomy effluent will be 
collected every 3 days, through 21 days after the first 
collection. The microorganisms colonising the proximal 
intestinal remnant will be identified using the 16S rRNA 
sequence analysis and a subset of microorganisms will be 
quantified using real- time PCR. This protocol may serve as 
basis for future observational and interventional studies on 
the modulation of the intestinal microbiota (eg, probiotics) 
on short and long- term outcomes in this population.
Ethics and dissemination This study protocol was 
approved by the Ethics Committee of Centro Hospitalar 
Universitário de Lisboa Central (441/2017) and by the 
Ethics Committee of NOVA Medical School, Universidade 
Nova de Lisboa (n°50/2018/CEFCM). The results will 
be spread through peer- reviewed publications and 
presentations at international scientific meetings.
trial registration number NCT03340259.
bACkground
The human microbiota is a collection 
of microbes living in the human body. It 
contains approximately 1014 cells and is 
mainly composed of bacteria. Most of these 
microorganisms reside in the gastrointestinal 
tract, constituting the gut microbiota.1–3
The gut microbiota, which is increasingly 
regarded as an ‘organ’, plays a major role in 
the maintenance of the host health, including 
intestinal health and function.4
The intestinal colonisation is dynamic and 
the microbial population develops rapidly 
from birth.5 6 Host- microbiome interaction in 
early life is crucial for the development of the 
barrier function and integrity as well as the 
mucosal and systemic immune functions.7
The type and diversity of intestinal micro-
organisms differ widely among neonates 
and are influenced by factors such as mode 
of delivery, gestational age, type of feeding, 
antibiotic exposure, infant postnatal age and 
surrounding environment.4 5 7–9 Under phys-
iological conditions, the rapid evolution of 
the infant microbiota depends on the initial 
contact with microbes by exposure to amni-
otic fluid, passage through the vaginal canal, 
intake of mother’s milk and skin- to- skin 
contact.10 In contrast, infants requiring inten-
sive care are usually nursed in high- sanitary 
incubators, receive antibiotics, have restricted 
mother’s milk intake and limited contact 
strengths and limitations of this study
 ► This is the first longitudinal study assessing the 
colonisation of the proximal intestinal remnant in 
infants requiring enterostomy.
 ► The enterostomy allows the study of the remnant 
proximal intestine microbiota.
 ► Data obtained may be useful for future preventive 
and therapeutic interventions.
 ► It is a single- centre study.
 ► The exposure to the previous neonatal unit environ-
ment may condition the newborn infants’ microbiota.
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Table 1 Studies and case reports addressing colonisation of proximal intestinal remnant in infants with enterostomy
Underlying 
condition Type of study Aim Sample size Results Reference
CMGIT, NEC and 
SIP
Randomised 
controlled trial
To determine the effect of an 
enteral oil supplementation 
on the intestinal microbiome
n=32 preterm 
infants (n=16 in 
each group)
Enrichment of many genera from 
Enterobacteriaceae family, including 
Escherichia, Pantoea, Serratia and 
Citrobacter over time, in infants 
receiving standard nutritional 
therapy.
Enteral oil supplementation 
increased bacterial diversity and 
decreased the abundance of 
pathogenic bacteria.
13
SIP and NEC Case report To study microbiota diversity 
according to the length of 
remnant intestine
n=2 preterm 
infants
Human infant ileum and colon are 
dominated by Bifidobacterium.
16
CMGIT and SIP Case report To quantify Lactobacillus and 
Bifidobacterium probiotic 
strains in the neonatal ileum
n=2 (1 preterm 
and 1 term infant)
Lactobacillus and Bifidobacterium 
strains were identified in the 
neonatal ileum.
17
CMGIT Case report To study the effect of 
probiotic therapy after 
CMGIT surgery
n=2 (1 preterm 
and 1 term infant)
Probiotic therapy with Lactobacillus 
casei and Bifidobacterium breve 
was effective and these strains 
became well established in the 
intestine.
14
CMGIT, NEC and 
SIP
Observational 
study
To compare the microbiota 
composition in fresh intestinal 
tissue collected during 
surgery vs faecal samples
n=7 preterm or 
term infants
Intestinal bacteria diversity was 
higher in the intestinal tissue and 
in faecal samples adherent to the 
intestinal mucosa.
15
CMGIT, congenital malformation of the gastrointestinal tract; NEC, necrotising enterocolitis; SIP, spontaneous intestinal perforation.
with mother’s skin.11 In addition, infants undergoing 
surgery of the gastrointestinal tract commonly require 
some period of fasting, and often the use of gastric acid 
suppressant.12 These factors can cause early life dysbiosis, 
a delayed and suboptimal colonisation of the intestine, 
which has been associated with long- term morbidities in 
adulthood.4 6
Preterm infants are immunologically immature and 
especially sensitive and responsive to bacteria colonising 
the intestine.11 The type of colonising bacteria may influ-
ence their risk of life- threatening morbidities, including 
late onset sepsis or necrotising enterocolitis (NEC).7
Newborn infants with congenital malformations of 
the gastrointestinal tract (CMGIT), NEC and sponta-
neous intestinal perforation (SIP) commonly require 
abdominal surgery and enterostomy.13 While intestinal 
microbiota has been extensively studied in infants with 
anatomically uninterrupted intestine, an extensive review 
of the literature retrieved only five studies or case reports 
addressing intestinal colonisation in infants with enteros-
tomy (table 1).13–17 Data from these studies and reports 
lack for clarification on to what extent the surgical inter-
ruption of intestine affects the developing intestinal 
microbiota.
In this regard, this is the first study that explores the 
intestinal colonisation over time in newborn infants with 
enterostomy.
The primary aim of this study is to obtain prospective 
data on the microbiota colonisation of the proximal 
intestinal remnant in newborn infants with enterostomy 
undergoing surgery due to CMGIT, NEC and SIP. The 
secondary objective is to explore associations between the 
colonisation, and perinatal and postnatal factors.
Methods and analysis
Study design
This is an observational, longitudinal and prospective 
study, implemented at the Neonatal Intensive Care Unit 
(NICU) of the Hospital Dona Estefânia, Centro Hospi-
talar Universitário de Lisboa Central, and the NOVA 
Medical School, Universidade NOVA de Lisboa.
Patient and public involvement
Patients were not involved in the development of this 
protocol.
recruitment criteria
Patients admitted to the NICU of the Hospital Dona 
Estefânia during the neonatal period, to whom an 
enterostomy has been performed due to CMGIT, NEC or 
SIP, are eligible (table 2).
sample size
No published data are available to contribute to esti-
mate the needed sample size. Therefore, a convenience, 
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Table 2 Inclusion and exclusion criteria
Inclusion criteria Exclusion criteria
 ► Newborn infants with enterostomy 
after surgery
for CMGIT, NEC or SIP.
 ► Newborn admitted up to the 28th 
day after birth, if a term neonate, 
or admitted up to 42 weeks 
postconceptional age if born 
preterm.
 ► Diagnosis of 
inborn errors of 
metabolism.
CMGIT, congenital malformation of the gastrointestinal tract; NEC, 
necrotising enterocolitis; SIP, spontaneous intestinal perforation.
Figure 1 Schedule of effluent sampling during study period.
non- probabilistic, consecutive sample, limited in time, 
will be recruited. The study is planned to recruit partici-
pants over 2 years. Based on the 11 patients admitted to 
the same NICU from March 2016 to March 2017, who 
fulfil the eligibility criteria, it is estimated that approxi-
mately 20 infants will be recruited.
Intestinal effluent sampling and storage
The first sample will be collected when a sufficient 
enterostomy effluent is available (approximately 2 mL). 
The periodicity of sampling is determined by the every 
3- day routine change of ostomy bags. Any spill or leak 
from the stoma collection bag will be considered as lost 
for sampling due to potential contamination by skin 
flora. In these cases, the next effluent will be considered 
for collection. The period of 21 days scheduled for the 
longitudinal study was based on the average stay in the 
NICU after surgery of the aforementioned conditions 
(figure 1).
Samples will be transported conditioned in a thermal 
bag with ice and stored at −20°C at the NOVA Medical 
School until being analysed.
Microbiota analysis
Bacterial and fungi DNA will be extracted directly from 
intestinal effluent samples using a NZY Tissue gDNA 
Isolation Kit (NZYTech, Lisbon, Portugal) as previously 
described.18 Some modifications to this protocol were 
made according to the protocol by Zoetendal et al.19 In 
brief, 350 µL of buffer NT1 will be added to the enteros-
tomy effluent (2–5 mL) and incubated in a shaking bath 
at 80°C for 15 min. Samples will be centrifuged at 1500 
x g for 1 min. RNAse (4 mg/mL) will be added to 200 µL 
of supernatant for incubation at room temperature for 
5 min. Subsequently, 25 µL of proteinase K will be added 
for incubation in a shaking bath at 70°C for 10 min. The 
remaining steps will follow the manufacturer instruc-
tions.18 19 DNA quantification will be assessed with a 
NanoDrop spectrophotometer (Thermo Scientific, Wilm-
ington, Delaware, USA). The microorganisms colonising 
the proximal intestinal remnant will be identified using 
the 16S rRNA sequence analysis, as described.20 A subset 
of microorganisms will be quantified using real- time 
PCR.18 Primer sequences will be used to target bacterial 
16S rRNA gene and fungi 18S rRNA gene18 21–24 (table 3). 
The set of microorganisms quantified was chosen based 
on previous reports of microorganisms found in prema-
ture infants, infants under intensive care, infants with 
NEC5 11 25–28 and in adults subjected to gastrointestinal 
surgery.29 The microbiota analysis will be performed at 
NOVA Medical School.
Independent factors
The following factors that may influence gut microbiota 
composition will be recorded:
Perinatal factors: gestational age, mode of delivery 
(vaginal or caesarean section), Apgar scores at 1 and 
5 min, prenatal antibiotic exposure, sex, body weight, 
length and head circumference at birth.
Surgical factors: surgical condition (CMGIT, NEC and 
SIP), antimicrobial therapy previous to surgery, age at 
the enterostomy surgery, intestinal level of the proximal 
enterostomy, estimated length of proximal intestinal 
remnant, type of feeding before surgery.
Postsurgery factors: daily body weight, days of fasting, days 
on parenteral nutrition, central catheter and type, type 
of feeding, volume and mode of administration; antimi-
crobial therapy and prophylaxis, H2- receptor antagonists 
therapy, days on invasive ventilation; acute events, such 
as sepsis, daily characteristics of enterostomy effluent and 
date of discharge.
Primary outcome
The primary outcome is the longitudinal characterisation 
of postsurgical microbial colonisation of the proximal 
intestinal remnant. The set of the bacteria and fungi that 
will be searched (table 3) was chosen based on previous 
reports,8 13–17 27 30–32 considering the limited amount of 
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Table 3 Primer sequences and real- time PCR conditions used for microbiota analysis
Target group Primer sequence (5’−3’) Genomic DNA standard AT Reference
Universal F: AAACTCAAAKGAATTGACGG
R: CTCACRRCACGAGCTGAC
Bacteroides vulgatus
ATCC 8482
62 18
Staphylococcus F: GAT GTG CGA AAG CGT GGG GAT
R: GAA CTG AGA ACA ACT TTA TGG 
GA
S. aureus
ATCC 12600
60 24
Bifidobacterium F: CGC GTC YGG TGT GAA AG
R: CCC CAC ATC CAG CAT CCA
B. longum subspecies infantis
ATCC 15697
60 18
Bacteroides fragilis F: TCRGGAAGAAAGCTTGCT
R: CATCCTTTACCGGAATCCT
B. fragilis
ATCC 25285
60 21
Escherichia coli F: GTTAATACCTTTGCTCATTGA
R: ACCAGGGTATCTAATCCTGTT
E. coli
ATCC 25922
60 23
Candida F: TTGGTGGAGTGAT TTGTCTGCT
R: TCTAAGGGCATCACAGACCT G
C. albicans
ATCC10231
60 22
AT, anneling temperature (°C).
enterostomy effluent collected in the pilot cases, which in 
turn restricts the amount of DNA available for extraction 
and subsequent identification.
secondary outcomes
The secondary outcomes are the associations between 
the identified microorganisms, the timing of first identifi-
cation and the considered independent factors, based on 
previously reported drivers of intestinal colonisation in 
infants.4–12
statistical analysis
Descriptive subgroup analysis is planned to be performed 
taking into account the cause for the enterostomy: CMGIT, 
NEC or SIP. Additional descriptive subgroup analysis is 
planned to be performed taking into account other main 
independent variables: gestational age (term, 37–41 weeks; 
moderate to late preterm, 32–36 weeks; very preterm, 
28–31 weeks and extremely preterm, <28 weeks), age at the 
enterostomy, intestinal level of the proximal enterostomy 
(duodenostomy, jejunostomy, ileostomy or colostomy) and 
mode of feeding history. Inference multilayered subgroup 
analysis and multivariable analysis will depend on the 
sample size and heterogeneity.
Ethics and dissemination
Parents or legal representative of eligible infants will be 
asked for written informed consent to participate.
This study was registered at  ClinicalTrials. gov with 
the title ‘Intestinal colonisation in newborn infants with 
enterostomy’ (NCT03340259), on 13 November 2017.
The datasets used and/or analysed during the current 
study are available from the corresponding author on 
reasonable request. In addition, the results will be acces-
sible from updates at the  ClinicalTrials. gov registry. The 
results will be disseminated through peer- reviewed publica-
tion and presentation at international scientific meetings.
dIsCussIon
Early life dysbiosis plays a significant role in the patho-
genesis of NEC.33 The relative abundance of γ-proteo-
bacteria and the paucity of strictly anaerobes have been 
described prior to diagnosis of NEC.4 7 33 In addition, 
low bacterial diversity and potential pathogenic microor-
ganisms such as Clostridium spp, Escherichia coli, Klebsiella 
pneumoniae, torovirus, astrovirus, cytomegalovirus and 
Candida spp were found in infants with NEC.11 26 In the 
aetiopathogenesis of SIP the role of the intestinal micro-
biota has not been elucidated.34 Infants with enterostomy 
have specific factors that may affect the development of 
intestinal microbiota, including the interruption of the 
intestine and the intraluminal contact with air through 
the stoma.29 35 Nevertheless, enterostomy allows to study 
the remnant intestine microbiota located closer to the 
intestinal mucosa.16 27 We assume that identification of 
bacteria in enterostomy effluents may reflect colonisa-
tion in remnant intestine. This may be useful to orient 
preventive and therapeutic approaches, including the use 
of specific probiotics. Little is known about the effects of 
surgery on the microbiota composition of the intestine 
as a large number of microorganisms might be removed 
along with the intestine.
This study is the first assessing the longitudinal coloni-
sation of the proximal intestinal remnant in three distinct 
surgical conditions, addressing the first 3 weeks after the 
first feasible collection of enterostomy effluent. The 16S 
rRNA sequence analysis used has the advantage of iden-
tifying the whole microbiota. The targeted quantitative 
PCR with specific primers to genus/species allows the 
quantification of microbiota. A novel aspect of this study 
includes the 18S rRNA gene analysis to examine fungal 
elements that has been overlooked in similar studies. 
Finally, the comparison of the microbiota identified 
in different points of assessment will give an insight of 
changes over time.
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We acknowledge some limitations of this study. First, in 
a single- centre study it may be difficult to attain a suffi-
cient sample size to assure heterogeneity as the practice 
of antibiotics prescription may be different from the 
protocols of other NICUs. Second, as a tertiary referral 
centre for neonatal surgery, the NICU of the Hospital 
Dona Estefânia receives several infants from other NICUs 
where they were originally admitted and previously 
exposed to their environments. The microbiological 
characteristics of those original NICUs are not contem-
plated in this study. Nevertheless, this issue will probably 
be of minor importance when enterostomy is performed 
within the first postnatal hours. Finally, the contact with 
air through the ostomy may affect the colonisation by 
anaerobic bacteria.
This pioneer study is expected to be useful for future 
research in the target population as it may serve as a 
basis for observational and interventional studies eval-
uating the modulation of the intestinal microbiota (eg, 
prebiotics and probiotics) on short- term and long- term 
outcomes.
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